The Experts below are selected from a list of 194463 Experts worldwide ranked by ideXlab platform
Juneseuk Shin - One of the best experts on this subject based on the ideXlab platform.
-
Factors influencing nanotechnology Commercialization: an empirical analysis of nanotechnology firms in South Korea
Journal of Nanoparticle Research, 2013Co-Authors: Cheol-ju Lee, Sukap Lee, Myung S Jhon, Juneseuk ShinAbstract:Nanotechnology is a representative emerging technology in an embryonic stage. Due to the continuous support provided by both the public and private sectors of many countries, nanotechnologies have increasingly been commercialized in a wide array of industries, but also produce many Commercialization failures. Tackling this problem, we investigate key factors affecting the Commercialization of nanotechnologies. Identifying key factors of nanotechnology Commercialization through literature review and interview with CEOs, we collected data of 206 Korean nanotechnology-based companies, and analyzed the causal relationship between key factors and financial performance. Logistic and Tobit regression models are used. Overall, companies achieving successful Commercialization hold some common characteristics including consistent exploratory R&D, governmental funding, and nano-instrument/energy/environment-related products. Also, the use of potentially toxic materials makes Commercialization difficult even if the products are not toxic.
David W. Hobson - One of the best experts on this subject based on the ideXlab platform.
-
Commercialization of nanotechnology.
Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology, 2009Co-Authors: David W. HobsonAbstract:The emerging and potential commercial applications of nanotechnologies clearly have great potential to significantly advance and even potentially revolutionize various aspects of medical practice and medical product development. Nanotechnology is already touching upon many aspects of medicine, including drug delivery, diagnostic imaging, clinical diagnostics, nanomedicines, and the use of nanomaterials in medical devices. This technology is already having an impact; many products are on the market and a growing number is in the pipeline. Momentum is steadily building for the successful development of additional nanotech products to diagnose and treat disease; the most active areas of product development are drug delivery and in vivo imaging. Nanotechnology is also addressing many unmet needs in the pharmaceutical industry, including the reformulation of drugs to improve their bioavailability or toxicity profiles. The advancement of medical nanotechnology is expected to advance over at least three different generations or phases, beginning with the introduction of simple nanoparticulate and nanostructural improvements to current product and process types, then eventually moving on to nanoproducts and nanodevices that are limited only by the imagination and limits of the technology itself. This review looks at some recent developments in the Commercialization of nanotechnology for various medical applications as well as general trends in the industry, and explores the nanotechnology industry that is involved in developing medical products and procedures with a view toward technology Commercialization.
Cheol-ju Lee - One of the best experts on this subject based on the ideXlab platform.
-
Factors influencing nanotechnology Commercialization: an empirical analysis of nanotechnology firms in South Korea
Journal of Nanoparticle Research, 2013Co-Authors: Cheol-ju Lee, Sukap Lee, Myung S Jhon, Juneseuk ShinAbstract:Nanotechnology is a representative emerging technology in an embryonic stage. Due to the continuous support provided by both the public and private sectors of many countries, nanotechnologies have increasingly been commercialized in a wide array of industries, but also produce many Commercialization failures. Tackling this problem, we investigate key factors affecting the Commercialization of nanotechnologies. Identifying key factors of nanotechnology Commercialization through literature review and interview with CEOs, we collected data of 206 Korean nanotechnology-based companies, and analyzed the causal relationship between key factors and financial performance. Logistic and Tobit regression models are used. Overall, companies achieving successful Commercialization hold some common characteristics including consistent exploratory R&D, governmental funding, and nano-instrument/energy/environment-related products. Also, the use of potentially toxic materials makes Commercialization difficult even if the products are not toxic.
Philip R. Walsh - One of the best experts on this subject based on the ideXlab platform.
-
Innovation Nirvana or Innovation Wasteland? Identifying Commercialization strategies for small and medium renewable energy enterprises
Technovation, 2012Co-Authors: Philip R. WalshAbstract:A conceptual framework for determining the appropriate choice of Commercialization strategies when evaluating the market environment for Renewable Energy Technology (RET) is presented. A comprehensive review of the literature dealing with technology innovation and Commercialization strategies was undertaken to identify suitable theoretical constructs and empirical support from which to develop the framework. The principal claim of this research is that Commercialization of innovation in RET is influenced by two important market dimensions; RET demand (market-pull) and eco-sophistication of the market (technology-push). Measures are determined for each of these market dimensions and four distinct Commercialization environments are identified; Innovation Wasteland, Innovation Push, Innovation Pull and Innovation Nirvana. Each of these environments impacts the choice of Commercialization strategies. A k-means cluster analysis is employed using member countries of the OECD and emerging economies, such as Brazil, Russia, India, and China (BRIC), to illustrate the use of this framework in addressing the choice of Commercialization strategy to be employed in these jurisdictions. This study results in a diverse distribution of OECD and BRIC countries across all of the identified Commercialization environments. These findings have implications for small and medium RET firms, investors and energy policy makers.
Myung S Jhon - One of the best experts on this subject based on the ideXlab platform.
-
Factors influencing nanotechnology Commercialization: an empirical analysis of nanotechnology firms in South Korea
Journal of Nanoparticle Research, 2013Co-Authors: Cheol-ju Lee, Sukap Lee, Myung S Jhon, Juneseuk ShinAbstract:Nanotechnology is a representative emerging technology in an embryonic stage. Due to the continuous support provided by both the public and private sectors of many countries, nanotechnologies have increasingly been commercialized in a wide array of industries, but also produce many Commercialization failures. Tackling this problem, we investigate key factors affecting the Commercialization of nanotechnologies. Identifying key factors of nanotechnology Commercialization through literature review and interview with CEOs, we collected data of 206 Korean nanotechnology-based companies, and analyzed the causal relationship between key factors and financial performance. Logistic and Tobit regression models are used. Overall, companies achieving successful Commercialization hold some common characteristics including consistent exploratory R&D, governmental funding, and nano-instrument/energy/environment-related products. Also, the use of potentially toxic materials makes Commercialization difficult even if the products are not toxic.
